M4MM

Atai Gains Nasdaq Biotechnology Index Spot

NEW YORK – AtaiBeckley N.V., the clinical-stage biopharmaceutical firm born from the November merger of atai Life Sciences and Beckley Psytech, has secured a place in the Nasdaq Biotechnology Index (NBI), a move that underscores ...

Spain Cabinet Greenlights Medical Cannabis Framework

MADRID – Spain's Council of Ministers on Tuesday approved a royal decree that sets rules for prescribing Cannabis-based medicines through the public health system, marking the first formal step toward regulated access for patients facing ...

Atai Gains Nasdaq Biotechnology Index Spot

NEW YORK – AtaiBeckley N.V., the clinical-stage biopharmaceutical firm born from the November merger of atai Life Sciences and Beckley Psytech, has secured a place in the Nasdaq Biotechnology Index (NBI), a move that underscores ...

PharmAla Launches “MDXXF” Ticker Amid MDMA Research

LOS ANGELES- PharmAla Biotech Holdings Inc., a biotechnology company specializing in the research, development, and manufacturing of novel MDMA derivatives (MDXX class molecules), has announced the introduction of its new OTC ticker symbol, "MDXXF." This ...

FinCEN’s Corporate Transparency Act Has Arrived

NEW YORK- Enacted by Congress in 2021, the Corporate Transparency Act (CTA) went into effect on January 1, 2024 and affects more than 30 million American small businesses1 and many smaller foreign companies doing business ...

Subscribe To Our Newsletter